Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robin Patel

Showing results (571-580 of 596) with videos related to

Pageof 60
Sort By:
Science Translational Medicine|October 26, 2018
<i>Clostridioides difficile</i> uses amino acids associated with gut microbial dysbiosis in a subset of patients with diarrheaEric J Battaglioli, Vanessa L Hale, Jun Chen, et al.
Journal of Clinical Microbiology|November 1, 2016
Informing Antibiotic Treatment Decisions: Evaluating Rapid Molecular Diagnostics To Identify Susceptibility and Resistance to Carbapenems against Acinetobacter spp. in PRIMERS IIIScott R Evans, Andrea M Hujer, Hongyu Jiang, et al.
Journal of Clinical Microbiology|May 25, 2017
Correction for Evans et al., "Informing Antibiotic Treatment Decisions: Evaluating Rapid Molecular Diagnostics To Identify Susceptibility and Resistance to Carbapenems against Acinetobacter spp. in PRIMERS III"Scott R Evans, Andrea M Hujer, Hongyu Jiang, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 5, 2024
Guide to Utilization of the Microbiology Laboratory for Diagnosis of Infectious Diseases: 2024 Update by the Infectious Diseases Society of America (IDSA) and the American Society for Microbiology (ASM)J Michael Miller, Matthew J Binnicker, Sheldon Campbell, et al.
Antimicrobial Agents and Chemotherapy|March 11, 2020
ARGONAUT II Study of the <i>In Vitro</i> Activity of Plazomicin against Carbapenemase-Producing Klebsiella pneumoniaeMichael R Jacobs, Caryn E Good, Andrea M Hujer, et al.
Trials|December 28, 2022
Safety and microbiological activity of phage therapy in persons with cystic fibrosis colonized with Pseudomonas aeruginosa: study protocol for a phase 1b/2, multicenter, randomized, double-blind, placebo-controlled trialPranita D Tamma, Maria Souli, Michael Billard, et al.
Mbio|March 31, 2022
Accessory Genomes Drive Independent Spread of Carbapenem-Resistant Klebsiella pneumoniae Clonal Groups 258 and 307 in Houston, TXWilliam C Shropshire, An Q Dinh, Michelle Earley, et al.
Journal of Clinical Microbiology|January 7, 2018
Multicenter Evaluation of the Accelerate PhenoTest BC Kit for Rapid Identification and Phenotypic Antimicrobial Susceptibility Testing Using Morphokinetic Cellular AnalysisPreeti Pancholi, Karen C Carroll, Blake W Buchan, et al.
Annals of Surgical Oncology|August 7, 2014
Randomized trial of drain antisepsis after mastectomy and immediate prosthetic breast reconstructionAmy C Degnim, Tanya L Hoskin, Rushin D Brahmbhatt, et al.
Microbes and Infection|September 7, 2025
ESCMID workshop: Artificial intelligence and machine learning in medical microbiology diagnosticsMariella Greutmann, Karsten Borgwardt, Sarah Brüningk, et al.
Pageof 60

Showing results (571-580 of 596) with videos related to

Sort By:
Pageof 60
Science Translational Medicine|October 26, 2018
<i>Clostridioides difficile</i> uses amino acids associated with gut microbial dysbiosis in a subset of patients with diarrheaEric J Battaglioli, Vanessa L Hale, Jun Chen, et al.
Journal of Clinical Microbiology|November 1, 2016
Informing Antibiotic Treatment Decisions: Evaluating Rapid Molecular Diagnostics To Identify Susceptibility and Resistance to Carbapenems against Acinetobacter spp. in PRIMERS IIIScott R Evans, Andrea M Hujer, Hongyu Jiang, et al.
Journal of Clinical Microbiology|May 25, 2017
Correction for Evans et al., "Informing Antibiotic Treatment Decisions: Evaluating Rapid Molecular Diagnostics To Identify Susceptibility and Resistance to Carbapenems against Acinetobacter spp. in PRIMERS III"Scott R Evans, Andrea M Hujer, Hongyu Jiang, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 5, 2024
Guide to Utilization of the Microbiology Laboratory for Diagnosis of Infectious Diseases: 2024 Update by the Infectious Diseases Society of America (IDSA) and the American Society for Microbiology (ASM)J Michael Miller, Matthew J Binnicker, Sheldon Campbell, et al.
Antimicrobial Agents and Chemotherapy|March 11, 2020
ARGONAUT II Study of the <i>In Vitro</i> Activity of Plazomicin against Carbapenemase-Producing Klebsiella pneumoniaeMichael R Jacobs, Caryn E Good, Andrea M Hujer, et al.
Trials|December 28, 2022
Safety and microbiological activity of phage therapy in persons with cystic fibrosis colonized with Pseudomonas aeruginosa: study protocol for a phase 1b/2, multicenter, randomized, double-blind, placebo-controlled trialPranita D Tamma, Maria Souli, Michael Billard, et al.
Mbio|March 31, 2022
Accessory Genomes Drive Independent Spread of Carbapenem-Resistant Klebsiella pneumoniae Clonal Groups 258 and 307 in Houston, TXWilliam C Shropshire, An Q Dinh, Michelle Earley, et al.
Journal of Clinical Microbiology|January 7, 2018
Multicenter Evaluation of the Accelerate PhenoTest BC Kit for Rapid Identification and Phenotypic Antimicrobial Susceptibility Testing Using Morphokinetic Cellular AnalysisPreeti Pancholi, Karen C Carroll, Blake W Buchan, et al.
Annals of Surgical Oncology|August 7, 2014
Randomized trial of drain antisepsis after mastectomy and immediate prosthetic breast reconstructionAmy C Degnim, Tanya L Hoskin, Rushin D Brahmbhatt, et al.
Microbes and Infection|September 7, 2025
ESCMID workshop: Artificial intelligence and machine learning in medical microbiology diagnosticsMariella Greutmann, Karsten Borgwardt, Sarah Brüningk, et al.
Pageof 60